New Filings & Updated Terms (ending 3.13.20)

NEW FILINGS

Company: Ayala Pharmaceuticals Inc.
Symbol: AYLA
Description: They are a clinical-stage oncology company focused on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers, primarily in genetically defined patient populations.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Citigroup, Jefferies
Co-Manager(s): Oppenheimer, Raymond James
Filed: 3-6-20
Listed Cash Raise: $50m

Company: Albertsons Companies, Inc.
Symbol: ACI
Description: They are one of the largest food and drug retailers in the United States, with both strong local presence and national scale.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): BofA Securities, Goldman Sachs & Co., JP Morgan, Citigroup, Credit Suisse, Morgan Stanley, Wells Fargo, Barclays, Deutsche Bank Securities
Co-Manager(s): BMO Capital Markets, Evercore ISI, Guggenheim, Oppenheimer, RBC Capital, Telsey Advisory Group, MUFG, Academy Seacurities, Blaylock Van, LLC
Filed: 3-6-20
Listed Cash Raise: $100m

Company: Lyra Therapeutics, Inc.
Symbol: LYRA
Description: They are a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose and throat, or ENT, diseases.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): BofA Securities, Jefferies, William Blair
Co-Manager(s): BTIG
Filed: 3-6-20
Listed Cash Raise: $57.5m

Company: Zentalis Pharmaceuticals, LLC
Symbol: ZNTL
Description: They are a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Morgan Stanley, Jefferies, SVB Leerink, Guggenheim Securities
Filed: 3-6-20
Listed Cash Raise: $100m